BJ’s, Walmart, Target top the week’s headlines

In this week’s recap of the Top 10 most popular Supermarket News articles, 5 things: Is the drug store’s time up? ranked as the week’s top story. A recent article in Slate seems to think so, saying that drug chains’ “time may be up.” 

Other top stories:

• Walmart builds on prior-year gains with robust Q3
• JJ Fleeman tapped as new Ahold Delhaize USA CEO
• Podcast: People are staying in. Here’s what that means for ‘stomach share’
• CHPA, Dollar General pilot shelf tags to aid OTC medicine selection

In other news, Atop double-digit gains a year earlier, Target Corp. generated net and comparable sales growth in the fiscal 2022 third quarter, but earnings sank amid consumer economic concerns and the company’s ongoing efforts to “rightsize” inventory and costs.

For the quarter ended Oct. 29, net sales edged up 3.3% to $26.12 billion from $25.29 billion billion a year ago, when sales surged 13.2%. Total revenue came in at $26.52 billion, up 3.4% year over year, Minneapolis-based Target reported Wednesday.

Among other stores:

• U.S. online grocery sales decline over 3% for October
• 5 things: Ho Ho Hoooo boy we’re back on track
• Grocery stores help lift U.S. retail sales in October
• BJ’s posts Q3 sales gains, maintains aggressive expansion plans